Cartilage Degeneration Market Segments and Growth by 2027

The cartilage degeneration market is expected to reach US$ 14,580.10 million in 2027 from US$ 10,459.93 million in 2019. The market is estimated to grow with a CAGR of 4.4% from 2020-2027.

Cartilage plays an important role in smooth mechanical movements of bones and muscles. Degeneration of cartilage can lead to pain and chronic inflammation in joints. Furthermore, this damaged cartilage can potentially influence quality of the life. Continual research and development is leading to innovation of new techniques and methodologies to deal with damages cartilages. Some of these techniques comprises joint replacement, cell therapies, and chondroplasty amongst others.The global cartilage degeneration market is driven by factors such as growing number of sports injuries, and increasing prevalence of obesity. However, the high cost of cartilage repair hampers the market growth. Additionally, growing number of product approvals and developments are creating growth opportunities for the market players.

Market Insights

Increasing Prevalence of Obesity

Obesity has a considerable effect on the musculoskeletal system, resulting into degeneration of bones, cartilage, and ligaments. Moreover, the condition, along with other prominent factors, is strongly allied with the increased risk of rapid cartilage loss. The growing prevalence of obesity is likely to accelerate the incidence of cartilage degeneration, which will drive the market growth.

According to the study published by the World Health Organization (WHO) in 2020, the frequency of obesity among the worldwide population has tripled since 1975. Furthermore, according to the same study, 38 million children below 5 years of age were overweight in 2019 worldwide. This massive prevalence of obesity is likely to accelerate due to unhealthy lifestyles such as consumption of junk food, sedentary lifestyle, genetic conditions, and deprivation of mental health. For instance, according to a study published by the Centers of Disease Control and Prevention, the prevalence of obesity grew from 30.5% to 42.4% during past two decades in the US. Overweight conditions among players and athletes can lead to the increasing prevalence of sports injuries. For instance, according to a study published in the British Journal of Sports Medicine in 2015, athletes with BMI index more than 30 kg/m2 are highly susceptible generationto the sports injuries. Such association between obesity and cartilage degeneration is anticipated to drive the market growth by 2027.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Cartilage Degeneration Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Application Insights

Based on application, the cartilage degeneration market is segmented into knee, hip, and other applications. In 2019, the knee segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of knee injuries. For instance, according to study published on online newspaper, which is based on NCBI data, an estimated 1 in 4 adults suffer from chronic knee pain. Moreover, the prevalence of knee pain has witnessed massive growth of around 40.0% during past 4 decades. Furthermore, increasing awareness of benefits provided by cartilage repair is also anticipated to drive the growth of knee segment.

Procedure Type Insights

The cartilage degeneration market, by procedure type, is segmented into osteochondral transplant, chondroplasty, joint replacement, meniscus transplants, cell-based cartilage resurfacing, and other procedure types. The joint replacement segment held the largest share of the market in 2019, whereas the cell-based cartilage resurfacing segment is anticipated to register the highest CAGR in the market during the forecast period.

End User Insights

Based on end user, the cartilage degeneration market is segmented into hospitals and specialty clinics, ambulatory surgical centers and,academic & research institutes. The hospitals and specialty clinicssegment held the largest share of the market in 2019. Also, the segment is estimated to register the highest CAGR in the market during the forecast period.

Product launches and approvalsare the commonly adopted strategies by companies to expand their global footprintsand product portfoliostomeet the growing consumer demand. The cartilage degeneration marketplayers adopt the collaborationsstrategy to enlarge customer base worldwide, which also permits them to maintain their brand name globally.

Cartilage Degeneration Market Regional Insights

The regional trends and factors influencing the Cartilage Degeneration Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Cartilage Degeneration Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Cartilage Degeneration Market Report Scope

Cartilage Degeneration Market Players Density: Understanding Its Impact on Business Dynamics

The Cartilage Degeneration Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Cartilage Degeneration Market are:

1. Zimmer Biomet
2. CartiHeal Inc.
3. Vericel Corporation
4. Depuy Synthes
5. Anika Therapeutics, Inc.

Disclaimer: The companies listed above are not ranked in any particular order.

Global Cartilage degeneration market– ByProcedure type

• Osteochondral Transplant
• Chondroplasty
• Joint Replacement
• Meniscus Transplants
• Cell-based Cartilage Resurfacing
• Others Procedures

Global Cartilage degeneration market– By Application

• Knee
• Hip
• Other Applications

Global Cartilage degeneration market– By End User

• Hospitals and Specialty
• Clinics, Ambulatory Surgical Centres
• Academic and Research Institutes

Cartilage degeneration market– By Geography

• North America

  • US
  • Canada
  • Mexico

• Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific

• Middle East and Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa

• South and Central America

  • Brazil
  • Argentina
  • Rest of South America

Company Profiles

• Zimmer Biomet
• CartiHeal Inc.
• Vericel Corporation
• Depuy Synthes
• Anika Therapeutics, Inc.
• Conmed Corporation
• Arthrex,Inc.
• B. Braun Melsungen AG
• Stryker
• Smith and Nephew Plc..